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scRNA-seq. This motivates our inquiry of whether protein abundances in individual cells can be 1 accurately imputed by the cell's transcriptome. We propose cTP-net, a transfer learning 2 approach based on deep neural networks, that imputes surface protein abundances for scRNA-3 seq data. cTP-net relies, for model training, on accumulating public data of cells with paired 4 transcriptome and surface protein measurements. 5
Studies based on both CITE-seq and REAP-seq have shown that the relative abundance of 6 most surface proteins, at the level of individual cells, is only weakly correlated with the relative 7 abundance of the RNA of its corresponding gene 2, 3, 9 . This is due to technical factors such as 8 RNA and protein measurement error 10 , as well as inherent stochasticity in RNA processing, 9 translation and protein transport [11] [12] [13] [14] [15] . To accurately impute surface protein abundance from 10 scRNA-seq data, cTP-net employs two steps: (1) denoising of the scRNA-seq count matrix and 11
(2) imputation based on the denoised data through a transcriptome-protein mapping (Figure 1a ). 12
The initial denoising, by SAVER-X 16 , produces more accurate estimates of the RNA transcript 13 relative abundances for each cell. Compared to the raw counts, the denoised relative 14 expression values have significantly improved correlation with their corresponding protein 15 measurement (Figure 1b, S3a, S4ab ). Yet, for some genes, such as CD45RA, this correlation 16 for denoised expression is still extremely low. 17
The production of a surface protein from its corresponding RNA transcript is a complicated 18 process involving post-transcriptional modifications and transport 11 , translation 12 , post-19 translational modifications 13 and protein trafficking 14 . These processes depend on the state of 20 the cell and the activities of other genes 9, 15 . To learn the mapping from a cell's transcriptome to 21 the relative abundance for a given set of surface proteins, cTP-net employs a multiple branch 22 deep neural network (MB-DNN, Figure S1 ). Deep neural networks have recently shown success 23 in modeling complex biological systems 17, 18 , and more importantly, allow good generalization 24 across data sets 16, 19 . Generalization performance is an important aspect of cTP-net, as we would like to perform imputation on tissues that do not exactly match the training data in cell 1 type composition. Details of the cTP-net model and training procedure, as well as of alternative 2 models and procedures that we have tried, are in Methods and Supplementary Note. 3
To examine imputation accuracy, we first consider the ideal case where imputation is conducted 4 on cells of types that exactly match those in training data. For benchmarking, we used 5 peripheral blood mononuclear cells (PBMCs) and cordical blood mononuclear cells (CBMCs) 6 processed by CITE-seq and REAP-seq 2, 3 , described in Table S1 . We employed holdout 7 method, where the cells in each data set were randomly partitioned into two sets: a training set 8 with 90% of the cells and a holdout set with the remaining 10% of the cells for validation 9 (Methods, Figure S2a ). By law of large numbers, each cell type should be well represented in 10 both the training and validation sets. Figure 1b and S3a show that, for all proteins examined in 11 the CITE-seq PBMC data, cTP-net imputed abundances have higher correlation to the 12 measured protein levels, as compared with the denoised and raw RNA counts of the 13 corresponding genes. In most cases, the imputed values substantially improve upon the 14 denoised values as proxies for protein abundance. We obtained similar results for the CITE-seq 15 CBMC and REAP-seq PBMC data sets ( Figure S4ab ). 16
Next, we considered the generalization accuracy of cTP-net, testing whether it produces 17 accurate imputations for cell types that are not present in the training set. For each of the high-18
level cell types in each data set in Table S2 , all cells of the given type are held out during 19 training, and cTP-net ,trained on the rest of the cells, was then used to impute protein 20 abundances for the held out cells (Methods, Figure S2b ). Across all benchmarking data sets 21 and all cell types, these out-of-cell-type predictions are, as expected, inferior in accuracy to the 22 traditional holdout validation predictions above, but still greatly improve upon the corresponding 23
RNAs (Figure 2a, S4a ). This indicates that cTP-net provides informative predictions on cell types not present during training, vastly improving upon using the corresponding mRNA 1 transcript abundance as proxy for the protein level. 2
To further examine the case where cell types in the training and test data are not perfectly 3 aligned, we considered a scenario where the model is applied to perform imputation on a tissue 4 that differs from the training data. We trained cTP-net on PBMCs and then applied it to perform 5 imputation on CBMCs, and vice versa, using the data from Stoeckius et al. 3 
(Methods). Cord 6
blood is expected to be enriched for stem cells and cells undergoing differentiation, whereas 7 peripheral blood contains well-differentiated cell types, and thus the two populations are 8 composed of different but related cell types. Figure 2a and S3b shows the result on training on 9 CBMC and then imputing on PBMC. As expected, imputing across tissue markedly improves 10 the correlation to the measured protein level, as compared to the denoised RNA of the 11 corresponding gene, but is worse than imputation produced by model trained on the same 12 population. For practical use, we have trained a network using the two cell populations 13 combined, which indeed achieves better accuracy than a network trained on each separately 14 (Methods, Figure S3b , S4ac). The weights for this network are publicly available at 15 https://github.com/zhouzilu/cTPnet. 16
We then tested whether cTP-net's predictions are sensitive to the laboratory protocol, and in 17 particular, whether networks trained using CITE-seq data yields good predictions by REAP-18 seq's standard, and vice versa. Using a benchmarking design similar to above, we found that, in 19 general, cTP-net maintains good generalization power across these two protocols (Figure 2a , 20 S3b). 21
Seurat v3 anchor transfer 20 is a recent approach that uses cell alignment between data sets to 22
impute features for single cell data. For comparison, we applied Seurat v3 anchor transfer to the 23 holdout validation and out-of-cell-type benchmarking scenarios above (Methods). In the 24 validation scenario, we found the performance of cTP-net and Seurat v3 to be comparable, with cTP-net slightly better. cTP-net vastly improves upon Seurat in the out-of-cell-type scenario 1 (Figure 2a , S5a). This is because cTP-net's neural network, trained across a diversity of cell 2 types, learns a transcriptome-protein mapping that can more flexibly generalize to unseen cell 3 types. As shown by the cross-population and out-of-cell-type benchmarking above, cTP-net 4 does not require direct congruence of cell types across training and test sets. 5
So far, the correlations with measured protein abundance are computed across cells of all 6 types. Since the proteins considered are highly cell type specific, such cross-type correlations 7 are partly driven by the learning of cell type features, which are pronounced in the transcriptome 8 data. Does cTP-net also capture the variation in protein abundance within the major cell types? 9
As expected, within cell-type variation is harder to predict, but cTP-net's imputations 10 nevertheless achieve high correlations with measured protein abundance for a subset of 11 proteins and cell types ( Figure S3c, S4d ). Compared to Seurat v3, cTP-net's imputations align 12 more accurately with measured protein levels when zoomed into cells of the same type ( Figure  13 2b, S5b); see, for example, CD11c in CD14-CD16+ monocytes, CD2 in CD8 T cells, and CD19 14 in dendritic cells ( Figure 2c ). The learning of such within-type heterogeneity gives cTP-net the 15 potential to attain higher resolution in the discovery and labeling of cell states. 16
What types of features are being used by cTP-net to form its imputation? To interpret the 17 network, we conducted a permutation-based interpolation analysis, which calculates a 18 prediction influence score for each protein-gene pair (Methods, Figure S6 ). Interpolation can be 19 done using all cells, or cells of a specific type, the latter allowing us to probe relationships that 20 may be specific to a given cell type. As expected, at the level of the general population that 21 includes all cell types, the most influential genes for each protein are cell type specific genes 22 (Table S3 ), since most of these surface proteins are cell type markers, and thus "cell type" is a 23 key variable that underlies their heterogeneity. Within cell type interpolation, on the other hand, 24 reveals genes related to RNA processing, RNA binding, protein localization and biosynthetic process, in addition to immune-related genes that may be markers of cell sub-types (Table S4) . 1
This indicates that cTP-net combines different types of features, both cell type markers and 2 genes involved in RNA to protein conversion and transport, to achieve multiscale imputation 3 accuracy. 4
Having benchmarked cTP-net's generalization accuracy across immune cell types, tissues, and 5 technologies, we then applied the network trained on the combined set of PBMCs and CBMCs 6 from CITE-seq 3 to perform imputation for the Human Cell Atlas CBMC and bone marrow 7 mononuclear cells (BMMC) data sets. Figure 2e shows the raw RNA count and predicted 8 surface protein abundance for 10 markers across 7000 CBMCs in sample MantonCB2. (Similar 9 plots for the other 7 CBMC and 8 BMMC samples are shown in Figure S8 , S9). As expected 10 based on the CITE-seq and REAP-seq studies, the imputed protein levels differ markedly from 11 the RNA expression of its corresponding gene, displaying higher contrast across cell types and 12 higher uniformity within cell type. The imputed protein levels can serve as intermediate features 13
for the identification and labelling of cell states. For example, consider natural killer cells, in 14 which proteins CD56 and CD16 serve as indicators for immunostimulatory effector functions, 15
including an efficient cytotoxic capacity 21, 22 . We observe an opposing gradient of CD56 and 16 CD16 levels within transcriptomically derived NK cell clusters that reveal CD56 bright and CD56 dim 17 subsets, coherent with previous studies 3 (Figure 2f ). This gradient in CD56 and CD16, where 18 decrease in CD56 is accompanied by increase in CD16, is replicated across the 8 CBMC and 8 19 BMMC samples in HCA ( Figure S8, S9) . Consider also the case of CD57, which is a marker for 20 terminally differentiated "senescent" cells in the T and NK cell types. The imputed level of CD57 21 is low, almost zero, in CBMCs, and rises in BMMCs. This is consistent with expectation since 22 CD57+ NK cell and T cell populations grow after birth and with ageing 23-25 ( Figure S8, S9 ). This 23
shows that cTP-net, trained on a combination of CBMCs and PBMCs, can impute cell type and cell stage specific protein signatures in new data without explicitly being given the tissue of 1 origin. 2
Taken together, our results demonstrate that cTP-net can leverage existing CITE-seq and 3 REAP-seq datasets to predict surface protein relative abundances for new scRNA-seq data 4 sets, and the predictions generalize to cell types that are absent from, but related to those in the 5 training data. Our benchmarking was done on diverse populations of PBMC and CBMC immune 6 cells. With the accumulation of CITE-seq and REAP-seq data, cTP-net can be retrained to 7 improve in accuracy and diversify in predictable protein targets. These results underscore the 8 need for more diverse multi-omic cell atlases and demonstrate how such resources can be used 9
to enhance future studies. The cTP-net package is available both in Python and R at 10 https://github.com/zhouzilu/cTPnet. 11
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Stuart, T. & Satija, R. Integrative single-cell analysis. Nat Rev Genet 20, 257-272 (2019 Online Methods 1 Data sets and pre-processing 2 Table S1 summarizes the five data sets analyzed in this study: CITE-PBMC, CITE-CBMC, 3 REAP-PBMC, HCA-CBMC and HCA-BMMC. Among these, CITE-PBMC, CITE-CBMC and 4 REAP-PBMC have paired scRNA-seq and surface protein counts, while HCA-CBMC and HCA-5 BMMC have only scRNA-seq counts. For all scRNA-seq data sets, low quality gene (< 10 6 counts across cells) and low quality cells (less than 200 genes detected) are removed, and the 7 count matrix ( ) for all remaining cells and genes is used as input for denoising. scRNA data 8 denoising was performed with SAVER-X using default parameters. Denoised counts (Λ) were 9 further transformed with Seurat default LogNormalize function, 10 = ( Λ * 10,000 ) 11
Figure legends
where Λ is the denoised molecule count of gene in cell , and is the sum of all molecule 12 counts of cell . The normalized denoised count matrix is the training input for the subsequent 13 multiple branch neural network. For the surface protein counts, we adopted the relative 14 abundance transformation from Stoeckius et al. 3 . For each cell , 15
where is vector of antibody-derived tags (ADT) counts, and ( )) is the geometric mean of 17 . The network trained using this transformed relative protein abundance as the response 18 vector yields better prediction accuracy than the network trained using raw protein barcode 19 counts. 20 cTP-net neural network structure and training parameters Figure S1 shows the structure of cTP-net. Here, we have a normalized expression matrix of 1 cells and genes, and a normalized protein abundance matrix of the same cells and 2 surface proteins. Let's denote cTP-net as a function that maps from ℝ to ℝ . Starting from 3 the input layer, with dimension equals to number of genes , the first internal layer has 4 dimension 1000, followed by a second internal layer with dimension 128. These two layers are 5 designed to learn and encode features that are shared across proteins, such as features that 6 are informative for cell state and common processes such as cell cycle. The remaining layers 7 are protein specific, with 64 nodes for each protein that feed into a one node output layer giving 8 the imputed value. All layers except the last layer are fully connected (FC) with ReLU activation 9 function 26 , while the last layer is a fully connected layer with identity activation function for 10 output. The objective function here is, 11
where the loss a L1 norm. The objective function was optimized stochastically with Adam 27 . 13
Other variations of cTP-net, which we found to have inferior performance, are illustrated in more 14 details in Supplementary Note. 15
Benchmarking procedure 16
Validation set testing procedure. Figure S2a shows the validation set testing procedure. Given 17 limited amount of data, we keep only 10% of the cells as the testing set, and use the other 90% 18 of the cells for training. The optimal model was selected based on the testing error. 19
Out-of-cell type prediction procedure. We perform the out-of-cell type prediction based on 20 Figure S2b . This procedure mimics cross-validation, except that, instead of selecting the test set 21 cells randomly, we partition the cells by their cell types. Iteratively, we designate all cells of a 22
given cell type for testing and use the remaining cells for training. We then perform prediction on 23 the hold-out cell type using the model trained on all other cell types. In the end, every cell has been tested once and has the corresponding predictions. In the benchmark against the 1 validation set testing procedure, we limit comparisons to the same cells that were in the 2 validation set in the holdout scheme to account for variations between subsets. 3
Cell population and technology transfer learning procedure. To apply the models we trained in 4 validation set testing procedure to different cell populations and technologies, the inputs have to 5 be in the same feature space. Even though all data sets considered are from human cells, the 6 list of genes differs between experiments and technologies. Genes that are in the training data 7 but not in the testing data are filled with zeros. Because cTP-net utilizes overrepresented 8 number of genes to predict the surface proteins level, having a small number of genes missing 9 has little effect on the performance. After prediction, we selected only the shared proteins 10 between two data sets for comparison. 11
cTP-net interpolation 12
To better interpret the relationships that the neural network is learning, we developed a 13 permutation-based interpolation scheme that can calculate an influence score for each gene 14 in the imputation of each protein ( Figure S6 ). The idea is to assess how much changing the 15 expression value of certain genes in the training data affects the training errors for a given 16 model . In each epoch, we interpolate all of the genes in a stochastic manner. As shown by 17 Figure S6 , the batch of genes denote by was randomly sampled. For genes within , cell 18 labels were permuted. Here, the cell order within does not coordinate with protein abundance 19
. We then calculate the prediction error ( ) on the interpolated cells ( ) and further compare 20 with uninterpolated prediction error ( ).
is the influence score (relative importance) of gene 21 set to this model . We set batch size as 100 with 500 epochs. Furthermore, by picking 22 different cells to interpolate, we could identify gene influence score in different cell types. For 23 example, if matrix belongs to a given cell type, the cell type specific genes are consistent 24 across cells of the given cell type, and thus, the permutation will not influence these genes. 1
Genes that influence the surface protein abundance within the cell type, such as cell cycle 2 genes and protein synthesis genes, tend to be rewarded with high influence scores in such a 3 cell-type specific interpolation analysis. 4
For the top 100 highest influence scored genes from the following scenarios in CITE-PBMC: (1) 5 CD45RA in CD14-CD16+ monocytes, (2) CD11c in CD14-CD16+ monocytes, (3) CD45RA in 6 CD8 T cells, (4) CD45RA in CD4 T cells, (5) CD11c in CD14+CD16+ monocytes, (6) CD45RA 7 in dendritic cells, and (7) CD11c in dendritic cells, we employed a Gene Ontology analysis 28 8 which identify top 10 pathways based on GO gene sets with FDR q-value < 0.05 as significant 9 (Table S4) . 10
Seurat anchor-transfer analysis 11
We compared cTP-net with an anchor-based transfer learning method developed in Seurat v3 12 20 . For Seurat v3, RNA count data are normalized by LogNormalization method, while surface 13 protein counts are normalized by centered log-ratio (CLR) method. In validation test setting, we 14 used the same cells for training and testing as in cTP-net so as to be directly comparable to 15
